Literature DB >> 25064788

Chronic neuropathic pain in SCI: evaluation and treatment.

Elizabeth Roy Felix1.   

Abstract

Chronic neuropathic pain develops in approximately 40% of people after a spinal cord injury (SCI) and is notoriously difficult to treat. Because of the frequent presence of more than one pain type and the complex mechanisms and symptoms associated with pain in individuals with SCI, a thorough evaluation is important. This review includes an overview of the most recent guidelines for evaluating and classifying pain, suggestions for standardizing outcome measures for clinical use, and a review of the positive and negative evidence for pharmacologic and nonpharmacologic interventions to consider when treating individuals with SCI and chronic neuropathic pain. Published by Elsevier Inc.

Entities:  

Keywords:  Neuropathic pain; Nonpharmacologic treatment; Pain evaluation; Pain management; Pharmacologic treatment

Mesh：

Substances：

Year:  2014        PMID： 25064788     DOI： 10.1016/j.pmr.2014.04.007

Source DB:  PubMed          Journal:  Phys Med Rehabil Clin N Am        ISSN： 1047-9651            Impact factor:   1.784


  8 in total

1.  Treatments that are perceived to be helpful for non-neuropathic pain after traumatic spinal cord injury: a multicenter cross-sectional survey.

Authors:  Chung-Ying Tsai; Thomas N Bryce; Andrew D Delgado; Sara Mulroy; Bria Maclntyre; Susan Charlifue; Elizabeth R Felix
Journal:  Spinal Cord       Date:  2021-03-19       Impact factor: 2.772

2.  Precision spinal gene delivery-induced functional switch in nociceptive neurons reverses neuropathic pain.

Authors:  Takahiro Tadokoro; Mariana Bravo-Hernandez; Kirill Agashkov; Yoshiomi Kobayashi; Oleksandr Platoshyn; Michael Navarro; Silvia Marsala; Atsushi Miyanohara; Tetsuya Yoshizumi; Michiko Shigyo; Volodymyr Krotov; Stefan Juhas; Jana Juhasova; Duong Nguyen; Helena Kupcova Skalnikova; Jan Motlik; Hana Studenovska; Vladimir Proks; Rajiv Reddy; Shawn P Driscoll; Thomas D Glenn; Taratorn Kemthong; Suchinda Malaivijitnond; Zoltan Tomori; Ivo Vanicky; Manabu Kakinohana; Samuel L Pfaff; Joseph Ciacci; Pavel Belan; Martin Marsala
Journal:  Mol Ther       Date:  2022-05-05       Impact factor: 12.910

3.  Effectiveness of amitriptyline and lamotrigine in traumatic spinal cord injury-induced neuropathic pain: a randomized longitudinal comparative study.

Authors:  N Agarwal; M Joshi
Journal:  Spinal Cord       Date:  2016-08-16       Impact factor: 2.772

Review 4.  Interrelationship of Neurogenic Obesity and Chronic Neuropathic Pain in Persons With Spinal Cord Injury.

Authors:  Elizabeth R Felix; David R Gater
Journal:  Top Spinal Cord Inj Rehabil       Date:  2021

5.  Changes to Biceps and Supraspinatus Tendons in Response to a Progressive Maximal Treadmill-Based Propulsion Aerobic Fitness Test in Manual Wheelchair Users: A Quantitative Musculoskeletal Ultrasound Study.

Authors:  Mylène Leclerc; Cindy Gauthier; Rachel Brosseau; François Desmeules; Dany H Gagnon
Journal:  Rehabil Res Pract       Date:  2021-03-01

6.  Effectiveness of Hydrotherapy on Neuropathic Pain and Pain Catastrophization in Patients With Spinal Cord Injury: Protocol for a Pilot Trial Study.

Authors:  Andrés Reyes Campo; Sara Gabriela Pacichana-Quinayáz; Francisco Javier Bonilla-Escobar; Luz Miriam Leiva-Pemberthy; Maria Ana Tovar-Sánchez; Olga Marina Hernández-Orobio; Gloria-Patricia Arango-Hoyos; Adnan Mujanovic
Journal:  JMIR Res Protoc       Date:  2022-04-29

Review 7.  Intercellular communication and ion channels in neuropathic pain chronicization.

Authors:  Nunzio Vicario; Rita Turnaturi; Federica Maria Spitale; Filippo Torrisi; Agata Zappalà; Rosario Gulino; Lorella Pasquinucci; Santina Chiechio; Carmela Parenti; Rosalba Parenti
Journal:  Inflamm Res       Date:  2020-06-12       Impact factor: 6.986

8.  Promoting Long-Term Health among People with Spinal Cord Injury: What's New?

Authors:  Mary Ann McColl; Shikha Gupta; Karen Smith; Alexander McColl
Journal:  Int J Environ Res Public Health       Date:  2017-12-06       Impact factor: 3.390
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.